CytoReason receives $80m investment
23 July 2024Candesic provided commercial due diligence to the investors providing $80m of growth capital to pioneering AI drug discovery company CytoReason.…Duke Street invests in AGITO Medical
16 July 2024Leading mid-market private equity group Duke Street is acquiring mobile rental solutions and pre-owned imaging equipment and spare parts supplier…Nordic Capital acquires Sensio shares
13 July 2024Nordic Capital is acquiring a majority stake in Sensio, a leading provider in smart monitoring technology for elderly and social…Exponent acquiring Kingsbridge Health Group
10 July 2024Leading European private equity firm Exponent is acquiring Northern Ireland’s largest private healthcare provider Kingsbridge Healthcare Group (KHG).The Candesic team,…
Consortium buys RAD-x Group
19 March 2024A consortium of Swiss Life Asset Managers and Vesper Next Generation Infrastructure Fund I has reached a binding agreement to…Candesic provides vendor commercial due dilligence to HBSUK on its acquisition by AXA Health
27 February 2024Candesic is pleased to have assisted HBSUK with vendor commercial due diligence on its acquisition by insurance giant AXA Health on Friday. HBSUK supports public and…Candesic provided vendor commercial due diligence to Centene Corporation
22 January 2024We are pleased to announce that Candesic provided vendor commercial due diligence to Centene Corporation in the context of their sale of Operose Health to HCRG Care…Candesic provided commercial due diligence to TPG
13 December 2023Congratulations to the team at TPG on their majority investment in Outcomes First Group! Candesic provided commercial due diligence to TPG. Outcomes First Group is a leading…Candesic provided commercial due diligence to Ampersand Capital Partners
29 November 2023Congratulations to the Ampersand Capital Partners team on their investment in Julius Clinical Research! Candesic provided commercial due diligence to Ampersand Capital Partners. Julius Clinical is a leading…Candesic provided commercial due diligence to NorthEdge
21 November 2023Congratulations to NorthEdge on their acquisition of Torbay Pharmaceuticals. Candesic provided commercial due diligence to NorthEdge. Torbay Pharmaceuticals is a fast growing specialist sterile injectable contract manufacturer. The…
